SEIZMET TRIO 0.2

Glimepiride 2 Metformin 500 Voglibose 0.2 is an anti-diabetic combination drug used in the treatment of Type 2 Diabetes Mellitus (T2DM) in adults. This triple-drug formulation incorporates three established agents that reduce blood glucose through different mechanisms to support improved blood sugar control throughout the day.

For patients not adequately controlled on diet, exercise or single-drug therapy, this combination provides a comprehensive approach that targets fasting blood sugar, post-meal glucose spikes and insulin resistance simultaneously.

Product Information

Brand Name: SEIZMET TRIO 0.2 (Steris Healthcare Pvt Ltd)

Composition Name: Metformin Hydrochloride (SR) 500 mg, Glimepiride 2 mg & Voglibose 0.2 mg Tablets

Formulation: Sustained-Release (SR) Tablet

Pack Size: 4 x 15 Tablets

Marketed By: Steris Healthcare Pvt Ltd

Regulatory Standard: WHO-GMP Certified Manufacturing Facility

Therapeutic Category: Anti-Diabetic Medicine

Indication: Management of Type 2 Diabetes Mellitus

Schedule: Valid Prescription Required (Prescription Only Medicine)

How Does Glimepiride 2 Metformin 500 Voglibose 0.2 Work?

Each ingredient works differently to help maintain healthy blood sugar levels.

Glimepiride 2 mg

Glimepiride belongs to the sulfonylurea class of medications. It stimulates the pancreas to release more insulin, helping lower blood glucose levels.

Benefits of Glimepiride

• Enhances insulin secretion
• Reduces fasting blood sugar
• Improves overall glycemic control

Metformin 500 mg

Metformin is considered one of the most trusted first-line treatments for Type 2 Diabetes.

Benefits of Metformin

• Reduces glucose production by the liver
• Improves insulin sensitivity
• Helps the body utilize insulin more efficiently
• Supports weight-neutral diabetes management

Voglibose 0.2 mg

Voglibose is an alpha-glucosidase inhibitor that slows carbohydrate digestion in the intestine.

Benefits of Voglibose

• Controls post-meal blood sugar spikes
• Delays glucose absorption
• Helps stabilize blood sugar fluctuations after eating

Why is Glimepiride 2 Metformin 500 Voglibose 0.2 Important?

Managing Type 2 Diabetes effectively requires control of both fasting and postprandial (after-meal) glucose levels.

Poorly controlled diabetes can lead to:

• Heart disease
• Kidney disease
• Vision problems
• Nerve damage
• Stroke
• Poor wound healing

The triple-action mechanism of Glimepiride 2 Metformin 500 Voglibose 0.2 helps address multiple causes of high blood sugar, making it a valuable option for long-term diabetes management.

Key Benefits 

Comprehensive Blood Sugar Control: This formulation targets fasting, post-meal, and overall blood glucose levels.

Triple Mechanism of Action: The three active ingredients work together for enhanced effectiveness compared to monotherapy.

Better HbA1c Management: Regular use can help patients achieve improved HbA1c levels under medical supervision.

Reduced Post-Meal Glucose Spikes: Voglibose specifically helps control sudden increases in blood sugar after meals.

Improved Insulin Utilization: Metformin enhances the body's response to insulin.

Convenient Combination Therapy: Combining three medications into one tablet may improve treatment adherence and convenience.

Long-Term Diabetes Support: Consistent glycemic control helps reduce the risk of diabetes-related complications.

Who Can Benefit from Glimepiride 2 Metformin 500 Voglibose 0.2?

Healthcare providers may prescribe this medication for:

• Adults with Type 2 Diabetes Mellitus
• Patients with uncontrolled blood sugar levels
• Individuals experiencing postprandial hyperglycemia
• Patients requiring combination diabetes therapy
• Those needing better HbA1c control

Side Effects

Like all medications, Glimepiride 2 Metformin 500 Voglibose 0.2 may cause side effects in some individuals.

Common Side Effects

• Nausea
• Stomach discomfort
• Diarrhea
• Gas and bloating
• Headache
• Dizziness

Precautions

• Monitor blood glucose regularly.
• Avoid skipping meals.
• Follow dietary recommendations.
• Attend routine diabetes checkups.
• Use caution while driving if prone to hypoglycemia.

Frequently Asked Questions 

What is Glimepiride 2 Metformin 500 Voglibose 0.2 used for?

It is used to manage Type 2 Diabetes Mellitus by improving blood sugar control through multiple mechanisms.

How does Glimepiride 2 Metformin 500 Voglibose 0.2 work?

Glimepiride increases insulin release, Metformin improves insulin sensitivity, and Voglibose slows carbohydrate absorption after meals.

Can Glimepiride 2 Metformin 500 Voglibose 0.2 lower HbA1c?

Yes. When taken as prescribed along with diet and exercise, it can help improve HbA1c levels.

Is this medicine suitable for newly diagnosed diabetes patients?

Treatment decisions depend on individual patient needs. A healthcare provider will determine the most appropriate therapy.

When should I take Glimepiride 2 Metformin 500 Voglibose 0.2?

It is typically taken with meals as directed by a physician.

Can this medication cause low blood sugar?

Yes. The Glimepiride component may increase the risk of hypoglycemia, especially if meals are skipped.

Does Voglibose help after-meal sugar control?

Yes. Voglibose specifically reduces post-meal blood sugar spikes by slowing carbohydrate digestion.

Can I take this medicine with other diabetes medications?

Only under medical supervision. Your doctor will evaluate potential interactions and treatment goals.

How long should I take Glimepiride 2 Metformin 500 Voglibose 0.2?

Diabetes management is often long-term. Continue treatment according to your doctor's recommendations.

What foods should be avoided while taking this medicine?

Limiting sugary foods, sweetened beverages, and refined carbohydrates can help improve blood sugar control.

Can Glimepiride 2 Metformin 500 Voglibose 0.2 help prevent diabetes complications?

Maintaining good blood glucose control may reduce the risk of long-term complications such as nerve damage, kidney disease, and cardiovascular issues.

Is regular blood sugar monitoring necessary?

Yes. Regular monitoring helps assess treatment effectiveness and supports better diabetes management.